4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid

C57H82N10O18S2 — CID 158792421

IUPAC4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid
SMILESCC[C@H](C)[C@@H]1CC(=O)CNC(=O)[C@H]2CC(=O)[C@H]([C@@H](C)[C@@H](O)CO)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS(=O)c3[nH]c4c(CSC5CN(C(=O)CCCCCNC(=O)CC(C)C(=O)O)C5)c(OC)ccc4c3C2)NC(=O)CNC1=O
InChIInChI=1S/C57H82N10O18S2/c1-6-28(2)36-17-32(69)20-60-51(77)31-15-37-35-11-12-44(85-5)38(26-86-34-23-66(24-34)48(76)10-8-7-9-13-59-46(74)14-29(3)57(82)83)50(35)65-55(37)87(84)27-40(62-47(75)21-61-52(36)78)53(79)63-39(19-45(58)73)56(81)67-22-33(70)18-41(67)54(80)64-49(42(71)16-31)30(4)43(72)25-68/h11-12,28-31,33-34,36,39-41,43,49,65,68,70,72H,6-10,13-27H2,1-5H3,(H2,58,73)(H,59,74)(H,60,77)(H,61,78)(H,62,75)(H,63,79)(H,64,80)(H,82,83)/t28-,29?,30-,31+,33+,36-,39-,40-,41-,43-,49-,87?/m0/s1
InChIKeyJGBQJAAXRFCDEQ-ZHZNLYJTSA-N
MW1259.47 g/mol
LogP-2.20
Rot. Bonds20

About 4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid

4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid (PubChem CID 158792421) has the molecular formula C57H82N10O18S2 and a molecular weight of 1259.47 g/mol. Its IUPAC name is 4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid.

Molecular Properties

Compound Name4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid
PubChem CID158792421
Molecular FormulaC57H82N10O18S2
Molecular Weight1259.47 g/mol
Exact Mass1258.52
IUPAC Name4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid
SMILESCC[C@H](C)[C@@H]1CC(=O)CNC(=O)[C@H]2CC(=O)[C@H]([C@@H](C)[C@@H](O)CO)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS(=O)c3[nH]c4c(CSC5CN(C(=O)CCCCCNC(=O)CC(C)C(=O)O)C5)c(OC)ccc4c3C2)NC(=O)CNC1=O
InChIInChI=1S/C57H82N10O18S2/c1-6-28(2)36-17-32(69)20-60-51(77)31-15-37-35-11-12-44(85-5)38(26-86-34-23-66(24-34)48(76)10-8-7-9-13-59-46(74)14-29(3)57(82)83)50(35)65-55(37)87(84)27-40(62-47(75)21-61-52(36)78)53(79)63-39(19-45(58)73)56(81)67-22-33(70)18-41(67)54(80)64-49(42(71)16-31)30(4)43(72)25-68/h11-12,28-31,33-34,36,39-41,43,49,65,68,70,72H,6-10,13-27H2,1-5H3,(H2,58,73)(H,59,74)(H,60,77)(H,61,78)(H,62,75)(H,63,79)(H,64,80)(H,82,83)/t28-,29?,30-,31+,33+,36-,39-,40-,41-,43-,49-,87?/m0/s1
InChIKeyJGBQJAAXRFCDEQ-ZHZNLYJTSA-N
XLogP-2.20
TPSA432.53 Ų
H-Bond Donors12
H-Bond Acceptors18
Rotatable Bonds20
Heavy Atoms87
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001259.47
LogP ≤ 5-2.20
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid?
The IUPAC name of 4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid (CID 158792421) is 4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid.
What is the SMILES notation for 4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid?
The canonical SMILES for 4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid is CC[C@H](C)[C@@H]1CC(=O)CNC(=O)[C@H]2CC(=O)[C@H]([C@@H](C)[C@@H](O)CO)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS(=O)c3[nH]c4c(CSC5CN(C(=O)CCCCCNC(=O)CC(C)C(=O)O)C5)c(OC)ccc4c3C2)NC(=O)CNC1=O.
What is the InChIKey of 4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid?
The InChIKey is JGBQJAAXRFCDEQ-ZHZNLYJTSA-N. The full InChI is InChI=1S/C57H82N10O18S2/c1-6-28(2)36-17-32(69)20-60-51(77)31-15-37-35-11-12-44(85-5)38(26-86-34-23-66(24-34)48(76)10-8-7-9-13-59-46(74)14-29(3)57(82)83)50(35)65-55(37)87(84)27-40(62-47(75)21-61-52(36)78)53(79)63-39(19-45(58)73)56(81)67-22-33(70)18-41(67)54(80)64-49(42(71)16-31)30(4)43(72)25-68/h11-12,28-31,33-34,36,39-41,43,49,65,68,70,72H,6-10,13-27H2,1-5H3,(H2,58,73)(H,59,74)(H,60,77)(H,61,78)(H,62,75)(H,63,79)(H,64,80)(H,82,83)/t28-,29?,30-,31+,33+,36-,39-,40-,41-,43-,49-,87?/m0/s1.
What are the key properties of 4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid?
4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid has a molecular weight of 1259.47 g/mol, XLogP of -2.20, 20 rotatable bonds, 12 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[6-[3-[[(1R,4S,8R,10S,13S,16R,34S)-4-(2-amino-2-oxoethyl)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-23-yl]methylsulfanyl]azetidin-1-yl]-6-oxohexyl]amino]-2-methyl-4-oxobutanoic acid is sourced from PubChem (CID 158792421), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).